Health Canada Clears New Kidney Drug for IgA Nephropathy
Health Canada approved Novartis's atrasentan (Vanrafia) to reduce proteinuria in adults with primary IgA nephropathy at risk of rapid disease progression, giving Canadian patients...
Read More — Health Canada Clears New Kidney Drug for IgA Nephropathy »